Skip to main content

Functionally Anuric

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Baxter International
1 program
Adjuvant Peritoneal Dialysis in the context of ongoing HemodialysisN/A
Baxter
BaxterCosta Rica - Cartago
1 program
Adjuvant Peritoneal Dialysis in the context of ongoing HemodialysisN/A1 trial
Active Trials
NCT02044614Terminated1Est. Apr 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BaxterAdjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis

Clinical Trials (1)

Total enrollment: 1 patients across 1 trials

NCT02044614BaxterAdjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis

Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis

Start: May 2014Est. completion: Apr 20161 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.